Newsletters

For the month of December 2018, Cadence Capital Limited returned a negative gross performance of 5.9% compared to a decrease in the All Ordinaries Accumulation Index of 0.5%. For the past month, the largest detractors from performance were ARQ Group Ltd, Emeco Holdings Ltd, Teva Pharmaceutical Industries Ltd, Nine Entertainment and Ausdrill Ltd. The largest […]

For the month of November 2018, Cadence Capital Limited returned a negative gross performance of 3.5% compared to a decrease in the All Ordinaries Accumulation Index of 2.2%. For the month, the largest positive contributors to performance were G8 Education Ltd, Stanmore Coal Ltd, and Teva Pharmaceutical Industries Ltd. The largest detractors from performance were […]

For the month of September 2018, Cadence Capital Limited returned a negative gross performance of 0.2%, compared to a decrease in the All Ordinaries Accumulation Index of 1.1%. As at the 30th September 2018 the fund is 83.9% invested (16.1% cash). On the 17th September 2018, the Company paid a 4.0 cent fully franked final dividend. This […]

For the month of August 2018, Cadence Capital Limited returned a negative gross performance of 2.5%. compared to an increase in the All Ordinaries Accumulation Index of 1.2%. As at the 31st August 2018 the fund is 85.5% invested (14.5% cash). On the 7th August 2018, the Company announced a 4.0 cent fully franked final dividend. This equates […]

For the month of July 2018, Cadence Capital Limited returned a gross performance of -0.1%. compared to an increase in the All Ordinaries Accumulation Index of 1.2%. As at the 31st July 2018 the fund is 82.5% invested (17.5% cash). On the 7th August 2018, the Company announced a record full year profit after tax of […]